Folic Acid‐Modified Mesoporous Silica Nanoparticles for Cellular and Nuclear Targeted Drug Delivery

Fabiola Porta, Gerda E. M. Lamers, Jess Morrhayim, Antonia Chatzopoulou, Marcel J. M. Schaaf, Hans den Dulk, Claude Backendorf, Jeffrey I. Zink, Alexander Kros

Advanced Healthcare Materials · 2012 · 152 citations · 38 references

DOIFull text

Open access

Concepts

Abstract

Folic acid-modified mesoporous silica nanoparticles are designed for cellular and nuclear targeted drug delivery. Camptothecin is efficiently delivered to human cancer cells resulting in apoptosis without premature leakage. The folic acid moiety is an integral part of a rotaxane structure, which locks the drug molecules in the pores, preventing premature release. Upon folate receptor-mediated cell uptake, esterases cleave the rotaxane valves and camptothecin is released, resulting in apoptosis.

References

38